⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 16, 2024

Supplementary Data from N6-methyladenosine modification of FZR1 mRNA promotes gemcitabine resistance in pancreatic cancer

View Full Paper

Ask AI

Bookmark

Share

Abstract

Proteins identified in RNA pulldown and mass spectrometry analysis with FZR1[m6A] or FZR1[A].

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Su et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587523211 https://doi.org/10.1158/0008-5472.27028258

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Data from N6-methyladenosine modification of FZR1 mRNA promotes gemcitabine resistance in pancreatic cancer2024
2Supplementary Data from N6-methyladenosine modification of FZR1 mRNA promotes gemcitabine resistance in pancreatic cancer2024
3Supplementary Data from N6-methyladenosine modification of FZR1 mRNA promotes gemcitabine resistance in pancreatic cancer2024
4Data from N6-methyladenosine modification of FZR1 mRNA promotes gemcitabine resistance in pancreatic cancer2024
5Ferroptosis Suppression by the M 6 A Reader IGF2BP1 Underlies Gemcitabine Resistance in Pancreatic Ductal AdenocarcinomaOriginal Research · 2026